Holen Sie sich die Stockscreener-App
2.2153
7.31%
-0.1747
Handel nachbörslich:
2.22
0.0047
+0.21%
Schlusskurs vom Vortag:
$2.39
Offen:
$2.4
24-Stunden-Volumen:
29,382
Relative Volume:
0.84
Marktkapitalisierung:
$7.39M
Einnahmen:
$556.00K
Nettoeinkommen (Verlust:
$-5.28M
KGV:
-1.0352
EPS:
-2.14
Netto-Cashflow:
$-6.23M
1W Leistung:
-10.31%
1M Leistung:
-23.34%
6M Leistung:
-8.46%
1J Leistung:
-27.37%
1-Tages-Spanne:
$2.16
$2.4303
1-Wochen-Bereich:
$2.16
$2.585
52-Wochen-Spanne:
$1.27
$9.4699
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
Firmenname
Cyclerion Therapeutics Inc
Sektor
Branche
Telefon
617-621-7722
Adresse
301 BINNEY STREET, CAMBRIDGE, MA
Vergleichen Sie CYCN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
2.2153 | 7.66M | 556.00K | -5.28M | -6.23M | -2.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-20 | Eingeleitet | Truist | Buy |
| 2021-09-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-03 | Eingeleitet | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc Aktie (CYCN) Neueste Nachrichten
Forecasting Cyclerion Therapeutics Inc. price range with options dataJuly 2025 Final Week & Reliable Momentum Entry Alerts - Newser
Will breakout in Cyclerion Therapeutics Inc. lead to full recovery2025 Trading Volume Trends & Daily Profit Maximizing Tips - Newser
Is a relief rally coming for Cyclerion Therapeutics Inc. holders2025 Market Sentiment & Daily Stock Trend Reports - Newser
Is Cyclerion Therapeutics Inc. stock poised for growth2025 Risk Factors & Consistent Growth Equity Picks - Newser
Visualizing Cyclerion Therapeutics Inc. stock with heatmapsTrade Analysis Report & AI Powered Buy/Sell Recommendations - Newser
Can volume confirm reversal in Cyclerion Therapeutics Inc.Trade Signal Summary & Risk Managed Investment Strategies - Newser
Volume spikes in Cyclerion Therapeutics Inc. stock – what they mean2025 Price Action Summary & Safe Swing Trade Setup Alerts - Newser
is cyclerion therapeutics inc. trending in predictive chart modelsJuly 2025 Highlights & Community Supported Trade Ideas - Newser
Can Cyclerion Therapeutics Inc. recover in the next quarterJuly 2025 Trade Ideas & AI Powered Market Entry Ideas - Newser
Using data filters to optimize entry into Cyclerion Therapeutics Inc.2025 Pullback Review & Risk Managed Trade Strategies - Newser
How to forecast Cyclerion Therapeutics Inc. trends using time seriesOptions Play & Free Growth Oriented Trading Recommendations - Newser
Chart based analysis of Cyclerion Therapeutics Inc. trends2025 Sector Review & Safe Entry Point Alerts - Newser
Will Cyclerion Therapeutics Inc. outperform the marketBond Market & Safe Capital Investment Plans - Newser
Using data tools to time your Cyclerion Therapeutics Inc. exitMarket Risk Report & Consistent Income Trade Recommendations - Newser
Does Cyclerion Therapeutics Inc. qualify in momentum factor screening2025 Short Interest & Safe Swing Trade Setup Alerts - Newser
What’s the analyst consensus on Cyclerion Therapeutics Inc.2025 Key Highlights & Trade Opportunity Analysis - خودرو بانک
What’s Cyclerion Therapeutics Inc.’s historical returnRate Cut & Reliable Momentum Entry Alerts - خودرو بانک
Vascular Dementia Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Charsire Biotech Corp, ProNeurogen Therapeutics, Resverlogix, Cyclerion Therapeutics, CSPC-NBP - Barchart.com
Analyzing Cyclerion Therapeutics Inc. with multi timeframe chartsJuly 2025 Closing Moves & Safe Entry Zone Tips - Newser
How liquid is Cyclerion Therapeutics Inc. stock2025 Key Highlights & Real-Time Chart Breakout Alerts - خودرو بانک
Understanding Cyclerion Therapeutics Inc.’s price movement2025 Market Trends & Long Hold Capital Preservation Plans - Newser
Backtesting results for Cyclerion Therapeutics Inc. trading strategiesJuly 2025 WrapUp & Free Long-Term Investment Growth Plans - Newser
What analysts say about Cyclerion Therapeutics Inc. stockJuly 2025 Market Mood & Weekly Top Stock Performers List - خودرو بانک
Chart based exit strategy for Cyclerion Therapeutics Inc.Market Rally & High Yield Equity Trading Tips - Newser
Is Cyclerion Therapeutics Inc. trending in predictive chart modelsMarket Rally & Long-Term Safe Investment Ideas - Newser
Can Cyclerion Therapeutics Inc. generate free cash flowWeekly Investment Summary & Community Consensus Picks - خودرو بانک
Candlestick signals on Cyclerion Therapeutics Inc. stock todayEarnings Growth Report & Low Risk Entry Point Guides - Newser
Can trapped investors hope for a rebound in Cyclerion Therapeutics Inc.July 2025 Gainers & Free Reliable Trade Execution Plans - Newser
Long term hold vs stop loss in Cyclerion Therapeutics Inc.Market Performance Summary & Verified Momentum Stock Alerts - Newser
Can Cyclerion Therapeutics Inc. rally from current levelsPortfolio Growth Summary & Low Risk Growth Stock Ideas - Newser
Predicting Cyclerion Therapeutics Inc. trend using moving averagesJuly 2025 EndofMonth & Fast Momentum Entry Tips - Newser
Can a trend reversal in Cyclerion Therapeutics Inc. lead to recoveryRate Hike & Weekly Setup with ROI Potential - Newser
Visual analytics tools that track Cyclerion Therapeutics Inc. performanceMarket Activity Recap & Safe Entry Trade Reports - Newser
Published on: 2025-09-02 21:05:45 - خودرو بانک
Finanzdaten der Cyclerion Therapeutics Inc-Aktie (CYCN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):